DR. MANDIRA RAY MD NPI 1659338606

NPI Details

DR. Mandira Ray, MD is a hematology and oncology internal medicine in Boston, MA with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Mandira Ray, MD NPI is 1659338606. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

133 BROOKLINE AVE
BOSTON, MA
ZIP 02215-904
Phone: (617) 421-8726
Fax: (617) 421-8724

The NPI 1659338606 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Ferritin (blood protein) level (HCPCS:82728)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood creatinine level (HCPCS:82565)
• Red blood count, automated test (HCPCS:85045)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Total protein level, blood (HCPCS:84155)
• Folic acid level, serum (HCPCS:82746)
• Calcium level, total (HCPCS:82310)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, clotting time (HCPCS:85610)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)

The enumeration date for this NPI number is 4/26/2006 and was last updated on 2/25/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: